| 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the … G Mancia, G De Backer, A Dominiczak, R Cifkova, R Fagard, G Germano, ... European heart journal 28 (12), 1462-1536, 2007 | 12897* | 2007 |
| Clinical features and outcomes of takotsubo (stress) cardiomyopathy C Templin, JR Ghadri, J Diekmann, LC Napp, DR Bataiosu, ... New England Journal of Medicine 373 (10), 929-938, 2015 | 2643 | 2015 |
| Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 VL Feigin, BA Stark, CO Johnson, GA Roth, C Bisignano, GG Abady, ... The Lancet Neurology 20 (10), 795-820, 2021 | 2191 | 2021 |
| Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ... The Lancet 391 (10117), 219-229, 2018 | 983 | 2018 |
| Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial SJ Connolly, JW Eikelboom, J Bosch, G Dagenais, L Dyal, F Lanas, ... The Lancet 391 (10117), 205-218, 2018 | 415 | 2018 |
| EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators: Efficacy of perindopril in reduction of cardiovascular events … KM Fox Lancet 362, 782-788, 2003 | 347 | 2003 |
| Acute heart failure congestion and perfusion status–impact of the clinical classification on in‐hospital and long‐term outcomes; insights from the ESC‐EORP‐HFA Heart Failure … O Chioncel, A Mebazaa, AP Maggioni, VP Harjola, G Rosano, C Laroche, ... European journal of heart failure 21 (11), 1338-1352, 2019 | 264 | 2019 |
| Happy heart syndrome: role of positive emotional stress in takotsubo syndrome JR Ghadri, A Sarcon, J Diekmann, DR Bataiosu, VL Cammann, S Jurisic, ... European heart journal 37 (37), 2823-2829, 2016 | 232 | 2016 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 227 | 2024 |
| A novel clinical score (InterTAK Diagnostic Score) to differentiate takotsubo syndrome from acute coronary syndrome: results from the International Takotsubo Registry JR Ghadri, VL Cammann, S Jurisic, B Seifert, LC Napp, J Diekmann, ... European journal of heart failure 19 (8), 1036-1042, 2017 | 210 | 2017 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 181 | 2024 |
| In‐hospital and 1‐year mortality associated with diabetes in patients with acute heart failure: results from the ESC‐HFA Heart Failure Long‐Term Registry G Targher, M Dauriz, C Laroche, PL Temporelli, M Hassanein, ... European journal of heart failure 19 (1), 54-65, 2017 | 177 | 2017 |
| Metabolomics and type 2 diabetes risk: an updated systematic review and meta-analysis of prospective cohort studies J Morze, C Wittenbecher, L Schwingshackl, A Danielewicz, A Rynkiewicz, ... Diabetes Care 45 (4), 1013-1024, 2022 | 158 | 2022 |
| Quality of life in patients with coronary heart disease after myocardial infarction and with ischemic heart failure JM Moryś, J Bellwon, S Höfer, A Rynkiewicz, M Gruchała Archives of medical science 12 (2), 326-333, 2016 | 125 | 2016 |
| Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC‐HFA … P Rossignol, M Lainscak, MG Crespo‐Leiro, C Laroche, MF Piepoli, ... European journal of heart failure 22 (8), 1378-1389, 2020 | 121 | 2020 |
| Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction … AM Lincoff, M Roe, P Aylward, J Galla, A Rynkiewicz, V Guetta, M Zelizko, ... European heart journal 35 (37), 2516-2523, 2014 | 117 | 2014 |
| A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with … TJ Povsic, JP Vavalle, LH Aberle, JD Kasprzak, MG Cohen, R Mehran, ... European heart journal 34 (31), 2481-2489, 2013 | 107 | 2013 |
| Sex‐and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry M Lainščak, I Milinković, M Polovina, MG Crespo‐Leiro, LH Lund, ... European journal of heart failure 22 (1), 92-102, 2020 | 101 | 2020 |
| Guías de práctica clínica para el tratamiento de la hipertensión arterial 2007 G Mancia, G De Backer, AF Dominiczak, R Cifkova, R Fagard, G Germano, ... Revista Espanola de Cardiologna 60 (9), 968 e1-994, 2007 | 96 | 2007 |
| Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up PP Dimitrow, L Chojnowska, T Rudziński, W Piotrowski, L Ziołkowska, ... European Heart Journal 31 (24), 3084-3093, 2010 | 87 | 2010 |
